NewAmsterdam Pharma N.V. (NAMS)
NASDAQ: NAMS
· Real-Time Price · USD
25.06
-0.11 (-0.44%)
At close: Aug 15, 2025, 3:59 PM
24.69
-1.48%
After-hours: Aug 15, 2025, 06:42 PM EDT
NewAmsterdam Pharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | n/a | -39.53M | -92.18M | -16.65M | -36.35M | -87.25M | -42.54M | -46.09M | -36.31M | -38.64M | -40.45M | -4.88M | -1.12M | 1.25M | 817.94K | 1.49M | -1.1M | 2.4M |
Depreciation & Amortization | 45K | 52K | 51K | 28K | 17.7K | 13.96K | 5.17K | 6.15K | 25.63K | 8.28K | -14.74K | n/a | n/a | n/a | 3.5K | 3.5K | 3.5K | 3.5K |
Stock-Based Compensation | 15.18M | 15.21M | 9.41M | 8M | 7.72M | 7.37M | 5.06M | 5.56M | 5.09M | 7M | 1.9M | n/a | n/a | n/a | 262.25K | 262.25K | 262.25K | 262.25K |
Other Working Capital | n/a | 8.1M | -4.78M | -1.88M | -2.12M | -1.3M | 2.43M | 2.62M | -1.6M | -2.98M | -2.86M | 2.1M | 1.73M | -44.33K | 35.94K | 185.95K | -57.26K | 29.59K |
Other Non-Cash Items | -52.9M | -22.56M | 53.21M | -3.91M | 1.86K | 930.50 | 2.55M | 2.58M | -5.16M | 1.84K | 9.15M | 2.54M | -780.44K | -1.56M | -338.08K | -1.81M | 838.22K | -2.6M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | 10.35M | -7.98M | 28K | -13.59M | -9.43M | 2.43M | 2.62M | 2.56M | -533.34K | 58.6M | 2.1M | 1.73M | -44.33K | 40.2K | 185.95K | -57.26K | 29.59K |
Operating Cash Flow | -37.67M | -36.47M | -37.48M | -12.5M | -50.3M | -50.81M | -32.49M | -35.32M | -33.42M | -29.3M | 29.19M | -244.78K | -164.69K | -355.77K | 520.06K | -132.91K | -314.64K | -172.26K |
Capital Expenditures | -88K | -16K | -3K | -75K | -194.75K | -358.24K | -8.87K | -9.35K | 2.43K | -6.44K | -109.43K | n/a | n/a | n/a | -5K | -5K | -5K | -5K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -183.71M | -9.63M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 24.66M | 12.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | -62.18M | n/a | n/a | n/a | -2.59M | -2.59M | n/a | n/a | n/a | n/a | n/a | n/a | 5K | 717K | 717K | 717K |
Investing Cash Flow | -159.14M | 2.85M | -62.18M | -75K | -194.75K | -358.24K | -2.6M | -2.6M | 5.16M | -6.44K | -109.43K | n/a | n/a | n/a | -5K | 712K | 712K | 712K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 3.42M | 6.52M | 1.58M | 58K | 4.66M | 7.7M | 712.56K | 198.76K | 6.33M | 2.2M | 153.39M | n/a | n/a | -40.67K | 5.48M | -5K | 17.25M | 17.25M |
Financial Cash Flow | 3.42M | 6.52M | 456.61M | 58K | 4.34M | 184.41M | 19.87K | 198.76K | 5.8M | 2.2M | 153.39M | n/a | n/a | -40.67K | 17.25M | 17.25M | 17.25M | 17.25M |
Net Cash Flow | -184.56M | -23.32M | 349.01M | -7.98M | -47M | 130.92M | -30.1M | -32.65M | -22.51M | -24.29M | n/a | -204.05K | -124.91K | -367.09K | 530.36K | -116.85K | -323.49K | -126.46K |
Free Cash Flow | -37.76M | -36.48M | -37.48M | -12.58M | -50.49M | -51.17M | -32.5M | -35.33M | -33.42M | -29.31M | 29.08M | -244.78K | -164.69K | -355.77K | 515.06K | -137.91K | -319.64K | -177.26K |